Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020

臨床試験イメージングの世界市場:CT、MRI、PET、超音波、心エコー、X線

◆タイトル:Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020
◆商品コード:MAM-HIT-3751
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年9月23日
◆ページ数:149
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥598,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥704,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥863,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、臨床試験イメージングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、種類別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented into CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The CT segment will hold the largest share of the clinical trials imaging market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global clinical trials imaging market in 2015. Asia is expected to register the fastest growth.

The growth of this market is mainly driven by growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs. The high growth potential in emerging markets, provides new growth opportunities and development of innovative new imaging modalities, contrast agents, molecular probes & radiopharmaceuticals provides new growth trends to players in the clinical trials imaging market. Rising demand of multimodality imaging technology in clinical trials is the major trend of this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global clinical trials imaging market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
• Product Development/Innovation: Product portfolios of the top players in the clinical trials imaging market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical trials imaging market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various clinical trials imaging across geographies
• Market Diversification: Exhaustive information about new products, recent developments, and investments in the clinical trials imaging market

【レポートの目次】

1 Introduction (Page No. – 8)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitation
1.6 Stakeholders

2 Research Methodology (Page No. – 11)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 18)

4 Premium Insights (Page No. – 23)
4.1Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 26)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Modality
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increase in R&D Spending
5.3.1.2 Growth in the Pharmaceutical and Biotechnology Industries
5.3.1.3 Increasing Number of Cros
5.3.2 Restraints
5.3.2.1 High Implementation Cost of Imaging Systems
5.3.3 Opportunities
5.3.3.1 Emerging Economies
5.3.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, & Radiopharmaceuticals
5.3.4 Challenges
5.3.4.1 High Cost of Clinical Trials
5.3.4.2 High Cost of Pet
5.3.5 Trends
5.3.5.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials

6 Clinical Trials Imaging Market, By Product (Page No. – 35)
6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services
6.2.4 Trial Design Consulting Services
6.3 Software

7 Clinical Trials Imaging Market, By Modality (Page No. – 49)
7.1 Introduction
7.2 Computed Tomography
7.3 Magnetic Resonance Imaging
7.4 Ultrasound
7.5 Positron Emission Tomography
7.6 X-Ray
7.7 Echocardiography
7.8 Other Modalities

8 Clinical Trials Imaging Market, By End User (Page No. – 64)
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Medical Device Manufacturers
8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes
8.7 Other End Users

9 Geographic Analysis (Page No. – 79)
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 106)
10.1 Introduction
10.2 Strategic Overview
10.3 Leading Players in the Market
10.4 Competitive Situation and Trends
10.4.1 Agreements, Collaborations, and Partnerships
10.4.2 Acquisitions
10.4.3 New Product and Service Launches & Product Upgrades
10.4.4 Expansions
10.4.5 Other Developments

11 Company Profiles (Page No. – 115)
11.1 Introduction
11.2 Bioclinica, Inc.
11.2.1 Business Overview
11.2.2 Services Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Parexel International Corporation
11.3.1 Business Overview
11.3.2 Services Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.3.4.1 Financial Analysis
11.3.4.2 Strategic Analysis
11.4 Icon Public Limited Company
11.4.1 Business Overview
11.4.2 Services Offered
11.4.3 Recent Developments
11.4.4 MnM View
11.4.4.1 Financial Analysis
11.4.4.2 Strategic Analysis
11.5 Biomedical Systems Corporation
11.5.1 Business Overview
11.5.2 Services Offered
11.5.3 Recent Developments
11.5.4 MnM View
11.6 Virtualscopics, Inc.
11.6.1 Business Overview
11.6.2 Services Offered
11.6.3 Recent Development
11.6.4 MnM View
11.6.4.1 Financial Analysis
11.6.4.2 Strategic Analysis
11.7 Cardiovascular Imaging Technologies, LLC
11.7.1 Business Overview
11.7.2 Products & Services Offered
11.8 Intrinsic Imaging LLC
11.8.1 Business Overview
11.8.2 Services Offered
11.8.3 Recent Developments
11.9 Ixico PLC
11.9.1 Business Overview
11.9.2 Products & Services Offered
11.9.3 Recent Developments
11.10 Radiant Sage LLC
11.10.1 Business Overview
11.10.2 Products & Services Offered
11.10.3 Recent Developments
11.11 Worldcare Clinical, LLC
11.11.1 Business Overview
11.11.2 Services Offered
11.11.3 Recent Developments

12 Appendix (Page No. – 136)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables (73 Tables)

Table 1 Market Summary
Table 2 Increase in R&D Spending is Propelling the Growth of the Market
Table 3 High Implementation Cost of Imaging Systems to Restrain Market Growth
Table 4 Emerging Economies Offer Significant Growth Opportunities
Table 5 High Cost of Clinical Trials Pose A Challenge for the Market
Table 6 Rising Demand for Multimodality Imaging Technology in Clinical Trials is A Major Trend Observed in This Market
Table 7 Clinical Trials Imaging Market Size, By Product, 2013–2020 (USD Million)
Table 8 Clinical Trials Imaging Services Market Size, By Type, 2013–2020 (USD Million)
Table 9 Clinical Trials Imaging Services Market Size, By Region, 2013–2020 (USD Million)
Table 10 North America: Clinical Trials Imaging Services Market Size, By Country, 2013–2020 (USD Million)
Table 11 Clinical Trials Imaging Market Size for Operational Imaging Services, By Region, 2013–2020 (USD Million)
Table 12 North America: Market Size for Operational Imaging Services, By Country, 2013–2020 (USD Million)
Table 13 Clinical Trials Imaging Market Size for Read Analysis Services, By Region, 2013–2020 (USD Million)
Table 14 North America: Market Size for Read Analysis Services, By Country, 2013–2020 (USD Million)
Table 15 Market Size for System and Technical Support Services, By Region, 2013–2020 (USD Million)
Table 16 North America: Market Size for System and Technical Support Services, By Country, 2013–2020 (USD Million)
Table 17 Market Size for Trial Design Consulting Services, By Region, 2013–2020 (USD Million)
Table 18 North America: Market Size for Trial Design Consulting Services, By Country, 2013–2020 (USD Million)
Table 19 Software Market Size, By Region, 2013–2020 (USD Million)
Table 20 North America: Software Market Size, By Country, 2013–2020 (USD Million)
Table 21 Market Size, By Modality, 2013–2020 (USD Million)
Table 22 Market Size for CT, By Region, 2013–2020 (USD Million)
Table 23 North America: Market Size for CT, By Country, 2013–2020 (USD Million)
Table 24 Market Size for Mri, By Region, 2013–2020 (USD Million)
Table 25 North America: Market Size for Mri, By Country, 2013–2020 (USD Million)
Table 26 Market Size for Ultrasound, By Region, 2013–2020 (USD Million)
Table 27 North America: Market Size for Ultrasound, By Country, 2013–2020 (USD Million)
Table 28 Market Size for Pet, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for Pet, By Country, 2013–2020 (USD Million)
Table 30 Market Size for X-Ray, By Region, 2013–2020 (USD Million)
Table 31 North America: Market Size for X-Ray, By Country, 2013–2020 (USD Million)
Table 32 Market Size for Echocardiography, By Region, 2013–2020 (USD Million)
Table 33 North America: Market Size for Echocardiography, By Country, 2013–2020 (USD Million)
Table 34 Clinical Trials Imaging Market Size for Other Modalities, By Region, 2013–2020 (USD Million)
Table 35 North America: Market Size for Other Modalities, By Country, 2013–2020 (USD Million)
Table 36 Market Size, By End User, 2013–2020 (USD Million)
Table 37 Market Size for Pharmaceutical Companies, By Region, 2013–2020 (USD Million)
Table 38 North America: Market Size for Pharmaceutical Companies, By Country, 2013–2020 (USD Million)
Table 39 Market Size for Biotechnology Companies, By Region, 2013–2020 (USD Million)
Table 40 North America: Market Size for Biotechnology Companies, By Country, 2013–2020 (USD Million)
Table 41 Market Size for Medical Device Manufacturers, By Region, 2013–2020 (USD Million)
Table 42 North America: Market Size for Medical Device Manufacturers, By Country, 2013–2020 (USD Million)
Table 43 Market Size for Cros, By Region, 2013–2020 (USD Million)
Table 44 North America: Market Size for Cros, By Country, 2013–2020 (USD Million)
Table 45 Clinical Trials Imaging Market Size for Academic and Government Research Institutes, By Region, 2013–2020 (USD Million)
Table 46 North America: Market Size for Academic and Government Research Institutes, By Country, 2013–2020 (USD Million)
Table 47 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 48 North America: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 49 Market Size, By Region, 2013–2020 (USD Million)
Table 50 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 51 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 52 North America: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 53 North America: Market Size, By Modality, 2013–2020 (USD Million)
Table 54 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 55 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 56 Europe: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 57 Europe: Market Size, By Modality, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 59 Asia: Market Size, By Product, 2013–2020 (USD Million)
Table 60 Asia: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 61 Asia: Market Size, By Modality, 2013–2020 (USD Million)
Table 62 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 63 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 64 RoW: Clinical Trials Imaging Services Market Size, By Type, 2013-2020 (USD Million)
Table 65 RoW: Market Size, By Modality, 2013–2020 (USD Million)
Table 66 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 67 Rank of Companies in the Global Clinical Trials Imaging Market, 2015
Table 68 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Players Between January 2013 and August 2015
Table 69 Agreements, Collaborations, and Partnerships, 2013–2015
Table 70 Acquisitions, 2013–2015
Table 71 New Product and Service Launches & Product Upgrades, 2013–2015
Table 72 Expansions, 2013–2015
Table 73 Other Developments, 2013–2015

List of Figures (76 Figures)

Figure 1 Clinical Trials Imaging Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Trials Imaging Market Size, By Product, 2015 vs 2020 (USD Million)
Figure 8 Market Size, By Modality, 2015 vs 2020 (USD Million)
Figure 9 Market Size, By End User, 2015 vs 2020 (USD Million)
Figure 10 Clinical Trials Imaging Market: Geographic Snapshot (2015)
Figure 11 Market Size, By Region, 2015 vs 2020 (USD Million)
Figure 12 Emerging Economies Offer Significant Growth Opportunities for Market Growth
Figure 13 Services Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period
Figure 15 North America Market Segment Headed Toward Maturity
Figure 16 Clinical Trials Imaging Market: By Product
Figure 17 Clinical Trials Imaging Market: By Modality
Figure 18 Clinical Trials Imaging Market: By End User
Figure 19 Increase in R&D Spending Will Drive the Market
Figure 20 Increasing R&D Funding Boosting Growth in the Market
Figure 21 Number of Biotechnology Patents, By Country, 2012
Figure 22 Market Segmentation, By Product
Figure 23 Clinical Trials Imaging Services to Form the Largest Segment in 2015
Figure 24 Operational Imaging Services to Form the Largest and Fastest-Growing Segment in the Forecast Period
Figure 25 North America to Command Largest Share of the Clinical Trials Imaging Services Market in 2015
Figure 26 Asia to Be the Fastest-Growing Segment of the Operational Imaging Services Market in the Forecast Period
Figure 27 North America to Form the Largest Segment of the Read Analysis Services Market in 2015
Figure 28 Asia to Form the Fastest-Growing Segment of the System and Technical Support Services Market in the Forecast Period
Figure 29 North America to Command Largest Share of the Trial Design Consulting Services Market in the Forecast Period
Figure 30 Asia to Be the Fastest-Growing Segment of the Clinical Trials Imaging Software Market in the Forecast Period
Figure 31 Market Segmentation, By Modality
Figure 32 CT Segment to Command the Largest Share of the Market in 2015
Figure 33 North America Expected to Dominate the Clinical Trials Imaging Market for CT
Figure 34 Asia to Witness Highest Growth in the Market for Mri in the Forecast Period
Figure 35 North America Expected to Form the Largest Regional Segment for Ultrasound
Figure 36 Asia Expected to Be the Fastest-Growing Regional Segment for Pet Market Between 2015 and 2020
Figure 37 X-Ray Market in Asia to Witness Highest Growth in the Forecast Period
Figure 38 Echocardiography Segment to Witness Highest Growth in Asia
Figure 39 North America Dominates the Market for Other Modalities
Figure 40 Clinical Trials Imaging Market, By End User
Figure 41 Clinical Trials Imaging Market Size, By End User, 2015 (USD Million)
Figure 42 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 43 Pharmaceutical Companies Segment to Witness Highest Growth in Asia
Figure 44 North America to Command the Largest Share of the Biotechnology Companies Segment in 2020
Figure 45 North America to Dominate the Market for Medical Device Manufacturers in 2020
Figure 46 North America Expected to Dominate the Market for Cros
Figure 47 Public-Sector Research Funding is Driving the Growth of the Academic & Government Research Institutes End-User Segment
Figure 48 North America Dominates the Market for Academic and Government Research Institutes
Figure 49 Asia to Witness the Highest Growth in the Clinical Trials Imaging Market for Other End Users in the Forecast Period
Figure 50 Clinical Trials Imaging Market, By Region (Market Size and Growth Rate), 2015-2020
Figure 51 Clinical Trials Imaging Market in Asia Expected to Grow at the Highest Rate From 2015 to 2020
Figure 52 North America: Market Snapshot
Figure 53 U.S. Forms the Fastest-Growing Market in North America in 2015
Figure 54 Services are Estimated to Be the Largest Product Segment in North America (2015)
Figure 55 Operational Imaging Largest Services Segment in North America (2015)
Figure 56 CT Expected to Form for the Largest Modality Segment in North America in 2015
Figure 57 Pharmaceutical Companies to Form the Largest End-User Segment in North America in 2015
Figure 58 Services to Form the Largest Product Segment in Europe 2015
Figure 59 Operational Imaging Accounted for the Largest Share in the European Clinical Trials Imaging Market in 2015
Figure 60 CT Segment to Command the Largest Share of the European Clinical Trials Imaging Market in 2015
Figure 61 Pharmaceutical Companies to Form the Largest End-User Segment in Europe in 2015
Figure 62 Asia: Market Snapshot
Figure 63 Services to Form the Largest Product Segment in Asia (2015)
Figure 64 Operational Imaging to Form the Largest Services Segment in Asia in 2015
Figure 65 CT Segment to Account for the Largest Share of the Market in Asia
Figure 66 Pharmaceutical Companies to Form the Largest End-User Segment in Asia in 2015
Figure 67 Services to Form the Largest Product Segment in the RoW in 2015
Figure 68 Operational Imaging to Command the Largest Share in the RoW Clinical Trials Imaging Market (2015)
Figure 69 CT to Form the Largest Modality Segment in RoW in 2015
Figure 70 Pharmaceutical Companies to Form the Largest End-User Segment in RoW in 2015
Figure 71 Agreements, Partnerships, and Collaborations is the Key Growth Strategy Adopted By Players in the Market
Figure 72 Market Developments Between January 2013 and August 2015
Figure 73 Company Snapshot: Parexel International Corporation
Figure 74 Company Snapshot: Icon Public Limited Company
Figure 75 Company Snapshot: Virtualscopics, Inc.
Figure 76 Company Snapshot: Ixico PLC

【レポートのキーワード】

臨床試験イメージング、CT、MRI、PET、超音波、心臓超音波検査(心エコー)、X線、治療法、サービス、ソフトウェア、製薬、医療機器

★調査レポート[臨床試験イメージングの世界市場:CT、MRI、PET、超音波、心エコー、X線] ( Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020 / MAM-HIT-3751) 販売に関する免責事項
[臨床試験イメージングの世界市場:CT、MRI、PET、超音波、心エコー、X線] ( Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020 / MAM-HIT-3751) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆